4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001415889-24-010604
CEO sold 26,574 shares at $17.87 ($474,877)
- CEO acquired 51,999 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| DAVIS STEPHEN CEO | 2024-04-05 | Option exercise | +17,333 | 136,175 | D | ||
| DAVIS STEPHEN CEO | 2024-04-05 | Option exercise | +34,666 | 170,841 | D | ||
| DAVIS STEPHEN CEO | 2024-04-08 | Sale | −8,858 | $17.87 | $158,292 | 161,983 | D |
| DAVIS STEPHEN CEO | 2024-04-08 | Sale | −17,716 | $17.87 | $316,585 | 144,267 | D |
| Derivatives | |||||||
| DAVIS STEPHEN CEO | 2024-04-05 | Option exercise · Restricted Stock Units | −17,333 | 34,667 | D | ||
| DAVIS STEPHEN CEO | 2024-04-05 | Option exercise · Restricted Stock Units | −34,666 | 138,666 | D | ||
| Open-market sales · 26,574 sh · avg $17.87 · $474,877 | |||||||
Loading xslF345X05/form4-04092024_060410.xml…